Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HTh74 |
Human thyroid gland undifferentiated (anaplastic) carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J. W. Tay et al., J. of Thrombosis and Haemostasis, 2013, 11: 1547–1555, DOI: 10.1111/jth.12331 | Link | ||
HuH7.5 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | N. Hagen, Dissertation, 2013, Universität Hamburg | Link | ||
INS-1 832/13 |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Wu, PhD Thesis, 2014, University of Alberta | Link | ||
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-J. Stahnke et al., Cellular Signalling, 2014, 26 :1792-1799doi.org/10.1016/j.cellsig.2014.04.006 | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | K. Marek-Bukowiec et al., Genes and Immunity, 2016, 17: 313-320, doi:10.1038/gene.2016.25 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | N. Sahner, Dissertation, 2019, Technische Universität Darmstadt | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. P. Brucker et al., Int. J. of Oncology, 2016, 49:2399-2410; DOI: 10.3892/ijo.2016.3760 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | G. D. Maurer et al., Int. J. Mol. Sci.,2019, 20, 106, doi:10.3390/ijms20051061 | Link | |
LNcaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | G. Loubeau et al., PLoS ONE, 2014, 9(5): e96293, doi:10.1371/journal.pone.0096293 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J. Elvenes et al., PLoS ONE, 2011, 6(9): e24659, doi:10.1371/journal.pone.0024659 | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LßT2 |
Mouse pituary ganotrope cells | Mouse | brain | cell line | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | S. Sperduti et al., Int. J. Mol. Sci., 2019, 20, 5548, doi:10.3390/ijms20225548 | Link | |||
M3K |
Drug-resistant breast cancer cell line (derivative of MCF7) | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Chem. Biodiversity, 2019, 16: e1900332, DOI: 10.1002/cbdv.201900332 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDPC-23 |
Mouse immortalized odontoblast cell line | ATCC CRL-2537 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | H.-J. Oh et al., Biomaterials, 2015, 37: 208e217; doi.org/10.1016/j.biomaterials.2014.10.016 | ||
MDPC-23 |
Mouse immortalized odontoblast cell line | ATCC CRL-2537 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | O. H. Jung, Seoul National Universtity | Link | |
MDPC-23 |
Mouse immortalized odontoblast cell line | ATCC CRL-2537 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J.-C. Park et al., 2017, US 2017/0100458 A1 | Link | |
MEF |
Mouse embryonic fibroblasts | ATCC SCRC-1040 | Mouse | unknown | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene EASY | publication | R. B. El-Houri et al., Evidence-Based Compl. and Alter. Med., 2014, article 156398, doi.org/10.1155/2014/156398 | Link | |
MEF |
Mouse embryonic fibroblasts | ATCC SCRC-1040 | Mouse | unknown | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene EASY | publication | S. K. Chun et al., ACS Chem. Biol., 2014, 9: 703−710, doi.org/10.1021/cb400752k |